Radiobiological characteristics of solid tumours depending on the p53 status of the tumour cells, with emphasis on the response of intratumour quiescent cells.

[1]  K. Ono,et al.  Radiobiologic significance of apoptosis and micronucleation in quiescent cells within solid tumors following gamma-ray irradiation. , 2001, International journal of radiation oncology, biology, physics.

[2]  A. Takahashi.  Different inducibility of radiation- or heat-induced p53 -dependent apoptosis after acute or chronic irradiation in human cultured squamous cell carcinoma cells , 2001, International journal of radiation biology.

[3]  T. Yamada,et al.  LET dependency of heavy-ion induced apoptosis in V79 cells. , 2000, Journal of radiation research.

[4]  Y. Nishimura,et al.  Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells. , 2000, International journal of radiation oncology, biology, physics.

[5]  K. Ono,et al.  Usefulness of Tirapazamine as a Combined Agent in Chemoradiation and Thermo‐chemoradiation Therapy at Mild Temperatures: Reference to the Effect on Intratumor Quiescent Cells , 2000, Japanese journal of cancer research : Gann.

[6]  A. Takahashi,et al.  Transfection with mutant p53 gene inhibits heat-induced apoptosis in a head and neck cell line of human squamous cell carcinoma. , 2000, International journal of radiation oncology, biology, physics.

[7]  C Michiels,et al.  Role of HIF-1 as a transcription factor involved in embryonic development, cancer progression and apoptosis (review). , 2000, International journal of molecular medicine.

[8]  A. Nagler,et al.  Ascorbic acid inhibits apoptosis induced by X irradiation in HL60 myeloid leukemia cells. , 1999, Radiation research.

[9]  B. Wouters,et al.  Apoptosis, p53, and tumor cell sensitivity to anticancer agents. , 1999, Cancer research.

[10]  D. Siemann.  The tumor microenvironment: a double-edged sword. , 1998, International journal of radiation oncology, biology, physics.

[11]  M. Hiraoka,et al.  Simultaneous evaluation of radiation-induced apoptosis and micronuclei in five cell lines. , 1998, International journal of radiation biology.

[12]  A. Giaccia,et al.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. , 1998, Cancer research.

[13]  A. Takahashi,et al.  Contribution of protein kinase C to p53-dependent WAF1 induction pathway after heat treatment in human glioblastoma cell lines. , 1998, Experimental cell research.

[14]  R. Kanamaru,et al.  Screening the p53 status of human cell lines using a yeast functional assay , 1997, Molecular carcinogenesis.

[15]  L. Wiesmüller,et al.  p53 Protein Exhibits 3′-to-5′ Exonuclease Activity , 1996, Cell.

[16]  S. Lowe,et al.  Cancer therapy and p53. , 1995, Current opinion in oncology.

[17]  P. Pantazis,et al.  Evidence for a G2 checkpoint in p53-independent apoptosis induction by X-irradiation , 1995, Molecular and cellular biology.

[18]  G. Stark,et al.  p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[20]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[21]  M. Karin,et al.  p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes , 1994, Nature.

[22]  Stephen J. Elledge,et al.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest , 1994, Cell.

[23]  W. Kolch,et al.  Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. , 1994, Oncogene.

[24]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[25]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[26]  H. Weier,et al.  Analysis of radiation-induced micronuclei by fluorescence in situ hybridization (FISH) simultaneously using telomeric and centromeric DNA probes. , 1992, Radiation research.

[27]  K. Ang,et al.  Apoptosis in irradiated murine tumors. , 1991, Radiation research.

[28]  A. Levine,et al.  The p53 tumour suppressor gene , 1991, Nature.

[29]  T. Price.  Politics of electricity production , 1991, Nature.

[30]  K. Ono,et al.  A method for the selective measurement of the radiosensitivity of quiescent cells in solid tumors--combination of immunofluorescence staining to BrdU and micronucleus assay. , 1991, Radiation research.

[31]  S. Rockwell,et al.  Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. , 1984, International journal of radiation oncology, biology, physics.

[32]  K. Ono,et al.  Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells. , 1999, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[33]  N. Kobayashi,et al.  Accelerated reoxygenation of a murine fibrosarcoma after carbon-ion radiation. , 1999, International journal of radiation biology.

[34]  J. Hendry,et al.  Apoptosis and mitotic cell death: their relative contributions to normal-tissue and tumour radiation response. , 1997, International journal of radiation biology.

[35]  K. Ang,et al.  Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. , 1993, International journal of radiation biology.

[36]  M. Fenech,et al.  Micronuclei in cytokinesis-blocked lymphocytes of cancer patients following fractionated partial-body radiotherapy. , 1990, International journal of radiation biology.